Paragraph IV Patent Challenges: How Generic Drug Makers Beat Brand Patents
Paragraph IV patent challenges let generic drug makers legally fight brand patents to bring cheaper medicines to market. This system, created by the Hatch-Waxman Act, saves Americans billions annually and drives 90% of prescriptions.